239 related articles for article (PubMed ID: 22968629)
1. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
[TBL] [Abstract][Full Text] [Related]
2. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
3. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
4. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
[TBL] [Abstract][Full Text] [Related]
5. Ipsilateral breast tumor control following hypofractionated and conventional fractionated whole-breast irradiation for early breast cancer: a long-term follow-up.
Yoshida-Ichikawa Y; Horimoto Y; Shikama N; Yanagisawa N; Koyanagi A; Arakawa A; Saito M; Karasawa K
Breast Cancer; 2021 Jan; 28(1):92-98. PubMed ID: 32719997
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
[TBL] [Abstract][Full Text] [Related]
7. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
[TBL] [Abstract][Full Text] [Related]
8. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
[TBL] [Abstract][Full Text] [Related]
9. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
10. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
[TBL] [Abstract][Full Text] [Related]
11. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.
Zauls AJ; Watkins JM; Wahlquist AE; Brackett NC; Aguero EG; Baker MK; Jenrette JM; Garrett-Mayer E; Harper JL
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):21-9. PubMed ID: 20951508
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes.
Chan EK; Woods R; McBride ML; Virani S; Nichol A; Speers C; Wai ES; Tyldesley S
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):786-92. PubMed ID: 24606848
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated radiation therapy for breast ductal carcinoma in situ.
Hathout L; Hijal T; Théberge V; Fortin B; Vulpe H; Hogue JC; Lambert C; Bahig H; Provencher L; Vavassis P; Yassa M
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1058-63. PubMed ID: 24113057
[TBL] [Abstract][Full Text] [Related]
15. Skin toxicity and cosmesis after hypofractionated whole breast irradiation for early breast cancer.
Saksornchai K; Rojpornpradit P; Shotelersak K; Lertbutsayanukul C; Chakkabat C; Raiyawa T
J Med Assoc Thai; 2012 Feb; 95(2):229-40. PubMed ID: 22435254
[TBL] [Abstract][Full Text] [Related]
16. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
17. Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer.
Chapman BV; Rajagopalan MS; Heron DE; Flickinger JC; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):854-61. PubMed ID: 26530754
[TBL] [Abstract][Full Text] [Related]
18. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Smith BD; Bentzen SM; Correa CR; Hahn CA; Hardenbergh PH; Ibbott GS; McCormick B; McQueen JR; Pierce LJ; Powell SN; Recht A; Taghian AG; Vicini FA; White JR; Haffty BG
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):59-68. PubMed ID: 20638191
[TBL] [Abstract][Full Text] [Related]
19. Five year outcome of 145 patients with ductal carcinoma in situ (DCIS) after accelerated breast radiotherapy.
Ciervide R; Dhage S; Guth A; Shapiro RL; Axelrod DM; Roses DF; Formenti SC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e159-64. PubMed ID: 22579378
[TBL] [Abstract][Full Text] [Related]
20. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH; Link EK; Kunkler IH; Whelan TJ; Westenberg AH; Gruber G; Bryant G; Ahern V; Purohit K; Graham PH; Akra M; McArdle O; O'Brien P; Harvey JA; Kirkove C; Maduro JH; Campbell ID; Delaney GP; Martin JD; Vu TTT; Muanza TM; Neal A; Olivotto IA;
Lancet; 2022 Aug; 400(10350):431-440. PubMed ID: 35934006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
